First-line Treatment Strategies for BRAF-Mutant Metastatic Melanoma: BRAF/MEK Inhibitors

Source: Onc Live, May 2022

Experts discuss the use of BRAF and MEK inhibitors as first-line treatments for patients with metastatic melanoma.

READ THE ORIGINAL FULL ARTICLE